1353 Commodity Chemicals

BASF SE Monitor

Submitted by Swati Valecha on Mon, 2018-08-06 13:57

CR Monitor Issue:

2018/0804

Company covered:

BASF SE

Period End:

31 December, 2017

Report issued on 07 August 2018 covered the following practice issues:

Discussion of key audit matters included in audit report.

Separate disclosure of director and auditor responsibilities in the audit report.

Extended disclosures relating to the impacts of accounting standards, not yet effective including IFRS 9 "Financial instruments", IFRS 15 "Revenues from contracts with customers" and IFRS 16 "Leases".

Introduction of reconciliation showing movements in liabilities arising from financing activities following adoption of amendment to IAS 7 "Statement of cash flows".

Restatement of prior year segmental breakdown.

Yara International ASA Monitor

Submitted by 609607d4-597e-4... on Tue, 2018-07-24 15:01

CR Monitor Issue:

2018/0718

Company covered:

Yara International ASA

Period End:

31 December, 2017

Report issued on 24 July 2018 covered the following practice issues:

Disclosure of impact of new standards namely IFRS 9 "Financial instruments", IFRS 15 "Revenues from contracts with customers", and IFRS 16 "Leases".

Extended disclosure in respect of restructuring provision linked to decision to close industrial site.

Extended disclosure in respect of contingent liabilities and contingent assets.

Presentation of a reconciliation of movements in liabilities arising from financing activities following adoption of amendment to IAS 7 "Statement of cash flows"

Restatement of gains and losses on financial instruments without explanation.

Restatement of quantitative information linked to liquidity and currency risk disclosures.

Yara International ASA Monitor

Submitted by 8c8c9ce2-030d-4... on Tue, 2017-11-21 15:20

CR Monitor Issue:

2017/1109

Company covered:

Yara International ASA

Period End:

31 December, 2016

Report issued on 21 November 2017 covered the following practice issues:

Extended disclosure on expected impacts of impending new revenue standard.

Introduction of disclosure in relation to critical judgements.

Introduction of tabular presentation explaining future potential reversals of impairment.

Cash flows linked to divested assets disclosed separately in the cash flow statement.

Inclusion of contingent consideration within financial instruments disclosures.

Detail explanation of amendments to standards that are not yet effective.

Air Liquide Monitor

Submitted by Pratiksha Mandhane on Tue, 2017-10-10 13:45

CR Monitor Issue:

2017/1005

Company covered:

Air Liquide

Period End:

31 December, 2016

Report issued on 10 October 2017 covered the following practice issues:

Profit contribution of acquired business not disclosed.

Discontinued operations highlighted on the face of the income statement.

Enhanced disclosure of non-executive director remuneration.

Managing the environment and climate risks identified as new principal risk factor.

Bayer AG Monitor

Submitted by 8c8c9ce2-030d-4... on Tue, 2017-05-02 06:48

CR Monitor Issue:

2017/0502

Company covered:

Bayer AG

Period End:

31 December, 2016

Report issued on 2 May 2017 covered the following practice issues:

Change in reporting segments following the introduction of new organisational structure.

Results of discontinued operations analysed by business.

Introduction of discussion of key audit matters in the auditor’s report.

Yara International ASA Monitor

Submitted by 8f67ab75-5f45-4... on Mon, 2016-11-21 10:09

CR Monitor Issue:

2016/1110

Company covered:

Yara International ASA

Period End:

31 December, 2015

Report issued on 21 November 2016 covered the following practice issues:

Gain on business disposal recognised as other income.

Reporting of segmental information on new and old basis following change in the reporting structure.

Disclosure of transactions with the non-controlling interest holders.

Recognition of loss from impairment of interest in a joint venture.

Positive and negative impacts of impending lease standard reported.

Disclosure of new strategic risk.

Synthomer plc Monitor

Submitted by ea11e72b-32c4-4... on Mon, 2016-08-29 10:52

CR Monitor Issue:

2016/0809

Company covered:

Synthomer plc

Period End:

31 December, 2015

Report issued on 29 August 2016 covered the following practice issues:

Extended risk disclosures and presentation of viability statement looking forward for five years.

Presentation of key performance indicators in strategic report.

Brief discussion of new leases standard.

Velocys plc Monitor

Submitted by ea11e72b-32c4-4... on Tue, 2015-11-17 11:35

CR Monitor Issue:

2015/1104

Company covered:

Velocys plc

Period End:

31 December, 2014

Report issued on 17 November 2015 covered the following practice issues:

Restructuring of multi-year contract leads to negative revenue.

Divergence from corporate governance rules on audit committee expertise.

Contingent consideration classed at Level 3 of fair value hierarchy.

Changes in value of available for sale financial asset recognised in income statement.

Provisions & contingencies - Bayer AG

Period End:

31 December, 2014

Period End Date:

2014-12-31

Listing Status:

S&P Europe 350

ICB Industry Classification:

1353 Commodity Chemicals

Auditor:

PricewaterhouseCoopers

Annual Report:

Bayer AG Annual Report 2014 (PDF)

Provisions & contingencies - Bayer AG

Period End:

31 December, 2014

Period End Date:

2014-12-31

Listing Status:

S&P Europe 350

ICB Industry Classification:

1353 Commodity Chemicals

Auditor:

PricewaterhouseCoopers

Annual Report:

Bayer AG Annual Report 2014 (PDF)